AHK-Cu 20-50mg 1kit
AHK-Cu 20-50mg 1kit Price range: $29.00 through $39.00
Back to products
Bronchogen 20mg 1kit
Bronchogen 20mg 1kit Original price was: $96.00.Current price is: $79.00.

B7-33 2-10mg 1kit

Price range: $61.00 through $208.00

B7-33 is a synthetic peptide investigated for its interaction with the relaxin receptor RXFP1 and its potential relevance to research into cellular signalling and tissue biology. Its distinct pharmacological profile has attracted interest in studies exploring relaxin-related pathways. Explore B7-33 at Titan Research Peptides for available product specifications and research documentation.

SKU: N/A Category:
Description

B7-33 Product Overview

B7-33 is a synthetic peptide developed as a selective agonist of the relaxin family peptide receptor 1 (RXFP1). It was designed as a shorter alternative to relaxin-2, the naturally occurring peptide hormone that activates this receptor and participates in several biological signalling pathways.

Research into B7-33 has focused on its interaction with RXFP1 and its potential to produce selected cellular responses associated with relaxin signalling. This makes B7-33 a subject of scientific interest in receptor pharmacology, cellular biology, and investigations of tissue remodelling.

For researchers examining B7-33 peptide, understanding its relationship with relaxin signalling provides useful context when evaluating the compound. The scientific properties of B7-33 should be distinguished from the verified specifications and quality of any particular research product.

Key Features and Research Benefits

  • Synthetic peptide: B7-33 is a designed peptide associated with relaxin receptor research.

  • RXFP1 receptor activity: Investigated for its ability to activate the relaxin family peptide receptor 1.

  • Distinct molecular structure: Developed as a shorter alternative to the naturally occurring relaxin-2 peptide.

  • Cellular signalling research: Studied for its effects on selected pathways associated with relaxin receptor activation.

  • Preclinical research interest: Investigated in experimental models to better understand its pharmacological properties.

These characteristics describe the scientific background of B7-33 rather than guaranteeing particular effects or outcomes from a commercial product.

Specifications

The specifications below should be confirmed against the individual Titan Research Peptides product listing.

  • Product name: B7-33

  • Product type: Synthetic research peptide

  • Research area: Relaxin receptor signalling and cellular biology

  • Target receptor: RXFP1

  • Product quantity: Refer to the current product listing.

  • Purity: Confirm through available product-specific analytical documentation.

  • Formulation: Refer to the listed product details.

  • Storage requirements: Follow the manufacturer’s documented instructions.

B7-33 should not be assumed to have a particular quantity, purity level, formulation, or certification unless the relevant details are explicitly documented.

How to Use / What’s Included

B7-33 is a research compound, and its suitability depends on the requirements of the intended laboratory investigation.

Before evaluating a product, verify its identity, stated quantity, formulation, and available analytical documentation. Research protocols should be based on appropriate scientific literature and laboratory procedures rather than assumptions about a product’s characteristics.

The contents of a specific purchase should be confirmed through the product listing. Do not assume that a vial, solvent, laboratory accessories, or additional materials are included unless explicitly stated.

B7-33 is not an approved treatment for self-administration. Its research background should not be interpreted as evidence of established safety or efficacy for human use.

Why Choose Titan Research Peptides?

Titan Research Peptides provides an online catalogue for customers exploring research-focused peptide products. The available listings allow buyers to examine product information and compare compounds relevant to their research interests.

When evaluating B7-33, focus on the documented product identity, stated specifications, and any supporting analytical information. These details are more useful for assessing a research material than unsupported claims about purity, performance, or biological outcomes.

Review the current product listing for applicable purchasing terms and any available information about shipping, documentation, or product handling. If an important specification is missing, request clarification before ordering.

Frequently Asked Questions

What is B7-33 peptide?

B7-33 is a synthetic peptide developed to activate RXFP1, a receptor associated with relaxin signalling. It has been investigated in preclinical research to better understand receptor activity and selected cellular responses. Its scientific background does not establish the quality or effectiveness of a particular commercial product.

What does it target?

B7-33 has been studied for its activity at the relaxin family peptide receptor 1, also known as RXFP1. This receptor participates in signalling pathways associated with relaxin biology. The effects of receptor activation depend on the biological system and experimental conditions being investigated.

How is it different from relaxin-2?

B7-33 was developed as a shorter peptide alternative to relaxin-2, the naturally occurring hormone that activates RXFP1. Although the compounds are related through their receptor activity, they differ in molecular structure and should not be assumed to produce identical biological responses.

What should I check before purchasing B7-33?

Review the product identity, stated quantity, formulation, available purity information, and supporting analytical documentation. Confirm that the information relates to the specific product being offered. If essential details are unavailable, contact the supplier for clarification before making a purchasing decision.

Is it approved for human use?

B7-33 is an investigational peptide rather than an established approved treatment. Preclinical findings do not establish safety or effectiveness in humans. Research-labelled materials should not be used for self-treatment or personal administration.

B7-33 at Titan Research Peptides

B7-33 is a specialised research peptide associated with RXFP1 activation and the broader field of relaxin receptor pharmacology. Its distinct molecular structure and preclinical research background make it relevant to scientific investigations of receptor signalling and cellular biology.

Explore the B7-33 listing at Titan Research Peptides to review available product specifications and supporting documentation. Evaluate the listed material according to your laboratory requirements and confirm any missing details before making a purchasing decision.

Additional information
Strength2mg, 10mg
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “B7-33 2-10mg 1kit”

Your email address will not be published. Required fields are marked *